Andreas Halvorsen acquired 1.82 Million Kinnate Biopharma shares worth $4.82 Million. That's 0.02% of their equity portfolio (82nd largest holding). The investor owns Inf% of the outstanding Kinnate Biopharma stock. Andreas Halvorsen started to build up the position in Kinnate Biopharma in Q4 2020. Since then they sold 51.6 Thousand shares. The investor's estimated purchase price is $73 Million, resulting in a loss of 93%.